Mofegiline
Mofegiline is a selective, irreversible inhibitor of monoamine oxidase B and semicarbazide-sensitive amine oxidase which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed.
Mofegiline is a selective, irreversible inhibitor of monoamine oxidase B and semicarbazide-sensitive amine oxidase which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed.